NCT07098143尚未招募不适用
Individualized Risk Factor Management Application for Reducing the Recurrence Risk of Stroke: A Multicenter, Randomized Controlled Trial Study
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 5,092
- 主要终点
- 1-year recurrence rate of stroke
研究概览
简要总结
This study applied an application that provides personalized suggestions and explore the effect of this actual intervention on reducing the risk of stroke recurrence
详细描述
This study applied an application that provides personalized suggestions based on participant's own secondary prevention risk factors status to stroke patients, enabling them to promptly take protective measures. And explore the effect of this actual intervention on reducing the risk of stroke recurrence after one year, as well as changes in other health-related indicators.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged 40 to 80, with no gender restrictions;
- •Acute ischemic stroke inpatients within 2 weeks of onset, where the onset time is the time when stroke symptoms appear or the last known normal time of the patient (when it is an onset during sleep or the symptom onset time cannot be accurately obtained due to aphasia, impaired consciousness, etc.);
- •Confirmed diagnosis of ischemic stroke by CT or MRI of the brain within 2 weeks after symptom onset; ④ Local residents (residing for ≥6 months); ⑤ Patients who voluntarily participate in the study, have high compliance, and can sign the informed consent form;
- •Patients who own a smartphone or other smart devices.
排除标准
- •Patients diagnosed with other cerebrovascular diseases (hemorrhagic stroke, transient ischemic attack, cerebral venous sinus thrombosis, etc.) or non-cerebrovascular diseases;
- •Known pregnant or lactating women, or those who tested positive on a pregnancy test before cluster randomization;
- •Patients with other conditions that may affect participation in the trial (e.g., refractory hypertension, severe aphasia, etc.);
- •Patients undergoing psychiatric/psychological treatment that may contaminate the results; ⑤ Patients with a life expectancy of less than one year (e.g., coexisting malignant tumors, severe cardiopulmonary diseases, etc.);
- •Patients already participating in other interventional clinical studies that may influence the outcome assessment; ⑦ Patients for whom the investigator deems unsuitable for participation in this study or who may pose significant risks to the patients (e.g., cognitive impairment preventing understanding and/or compliance with the study procedures and/or follow-up).
研究组 & 干预措施
Risk factor management group
Experimental
干预措施: Risk factor management (Other)
Routine education
No Intervention
结局指标
主要结局
1-year recurrence rate of stroke
时间窗: Intervention at the 1-year
次要结局
- System usability scale score(Intervention at 3-month, 6-month, 9-month and 1-year)
- NIH stroke scale score(Baseline)
- 3-month, 6-month, 9-month recurrence rate of stroke(Intervention at 3-month, 6-month, 9-month)
- Blood pressure(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- C-reactive protein(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- Modified rankin scale score(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- Health literacy scale score(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- Prothrombin time(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- Minimum mental state examination(Baseline; Intervention at 6-month and 1-year)
- Social support rate scale score(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- Electrocardiogram (ECG) parameters(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- Fasting blood glucose(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- International normalized ratio(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- Platelet count(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- D-dimer(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- European five-dimensional five-level health scale score(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- Depression anxiety stress scales - 21 score(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
- Activated partial thromboplastin time(Baseline; Intervention at 3-month, 6-month, 9-month and 1-year)
研究者
相似试验
招募中
不适用
UPTAKE - Virtual Care: Virtual Home Hospital With Remote Monitoring to Reduce Acute Care HospitalizationAcute Kidney InjuryNCT06537453University of Calgary354
已完成
不适用
Personalized Feedback Intervention to Reduce Risky Cannabis Use.Cannabis UseNCT04060602Centre for Addiction and Mental Health747
招募中
不适用
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE StudyHeart FailureNCT05679713Hospital Universitari de Bellvitge1,134
Unknown
不适用
Personalised Risk-based Breast Cancer Prevention and ScreeningBreast CancerNCT03989258Tartu University Hospital28,389
招募中
不适用
Online Personalized Intervention for the Prevention of Anxiety.Anxiety DisordersNCT05682365University of Malaga2,000